The Application Value of Spectral CT in the Accurate Staging of Liver Cancer
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 150
- 试验地点
- 1
- 主要终点
- Pathological TNM staging
研究概览
简要总结
Spectral CT was used to prospectively collect medical images and clinical data related to liver cancer, evaluate the effect of image quality in the diagnosis of liver cancer, and evaluate the application value in the accurate staging of liver cancer, so as to provide a more accurate clinical basis for diagnosis, promote the development of individualized treatment, and ultimately improve the prognosis of patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Undergo a contrast-enhanced Quark Spectral CT scan of the lower abdomen/pelvis within 1 week before treatment.
- •Age > 18 years.
- •Patients suspected of having liver cancer.
- •Patients who have signed the informed consent form.
排除标准
- •Severe cardiac, pulmonary, or renal insufficiency.
- •Allergy to iodine-based contrast agents.
- •Inability to cooperate with the CT examination.
- •Poor image quality of the Quark Spectral CT scan.
- •Women who are pregnant or breastfeeding.
研究组 & 干预措施
The application value of spectral CT in the accurate staging of liver cancer
Prospectively collect medical images and clinical data related to liver cancer using Philips Quark CT equipment, and evaluate the diagnostic accuracy and clinical application value in the accurate staging of liver cancer.Patients diagnosed with liver cancer in Yunnan Provincial Cancer Hospital from April 2025 to May 2026 were consecutively included, and after scanning with Philips Quark CT, the TNM stage of liver cancer patients was assessed by two radiologists, and finally statistical analysis was performed.
干预措施: To explore the value of spectral CT in the diagnosis and treatment of liver cancer (Diagnostic Test)
结局指标
主要结局
Pathological TNM staging
时间窗: 1 day
Pathological examination information: The pathology results using surgery/biopsy data are the gold standard, and the depth of tumor invasion, lymph node metastasis, and distant metastasis are recorded
次要结局
未报告次要终点